Triple

T22693405
Position Surface form Disambiguated ID Type / Status
Subject RNA polymerase II E561106 entity
Predicate interactsWith P3970 FINISHED
Object TFIIB NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: TFIIB | Statement: [RNA polymerase II, interactsWith, TFIIB]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: TFIIB
Context triple: [RNA polymerase II, interactsWith, TFIIB]
  • A. CTCF
    CTCF is a state prison facility in Colorado that houses incarcerated individuals under the jurisdiction of the Colorado Department of Corrections.
  • B. RNA polymerase II
    RNA polymerase II is the eukaryotic enzyme complex responsible for transcribing DNA into messenger RNA and many non-coding RNAs, playing a central role in gene expression.
  • C. MAFA transcription factor
    MAFA transcription factor is a beta cell–specific transcription factor that plays a key role in regulating insulin gene expression and pancreatic islet function.
  • D. FOXA2 transcription factor
    FOXA2 transcription factor is a forkhead box transcription factor that plays a key role in regulating genes involved in pancreatic beta-cell function, glucose metabolism, and endoderm development.
  • E. TARDBP
    TARDBP is a gene encoding the TDP-43 protein, a DNA/RNA-binding protein whose abnormal aggregation is a key pathological feature in amyotrophic lateral sclerosis and related neurodegenerative diseases.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: TFIIB
Target entity description: TFIIB is a general transcription factor that helps recruit and position RNA polymerase II at gene promoters to initiate transcription in eukaryotic cells.
  • A. CTCF
    CTCF is a state prison facility in Colorado that houses incarcerated individuals under the jurisdiction of the Colorado Department of Corrections.
  • B. RNA polymerase II
    RNA polymerase II is the eukaryotic enzyme complex responsible for transcribing DNA into messenger RNA and many non-coding RNAs, playing a central role in gene expression.
  • C. MAFA transcription factor
    MAFA transcription factor is a beta cell–specific transcription factor that plays a key role in regulating insulin gene expression and pancreatic islet function.
  • D. fibrillarin
    Fibrillarin is a highly conserved nucleolar protein that functions as a core component of small nucleolar ribonucleoproteins (snoRNPs), playing a key role in rRNA processing and ribosome biogenesis.
  • E. FOXA2 transcription factor
    FOXA2 transcription factor is a forkhead box transcription factor that plays a key role in regulating genes involved in pancreatic beta-cell function, glucose metabolism, and endoderm development.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e2454d71b48190a1f80af9f82b6fcf completed April 17, 2026, 2:35 p.m.
NER Named-entity recognition batch_69f1789c6ae481908975b7d27e7624ac completed April 29, 2026, 3:18 a.m.
Created at: April 17, 2026, 3:13 p.m.